VIVO
Meridian Bioscience Inc
VIVO
VIVO
Delisted
VIVO was delisted on the 30th of January, 2023.
215 hedge funds and large institutions have $1.08B invested in Meridian Bioscience Inc in 2021 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 69 increasing their positions, 75 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
8% less repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 75
35% less call options, than puts
Call options by funds: $6.29M | Put options by funds: $9.63M
Holders
215
Holding in Top 10
2
Calls
$6.29M
Puts
$9.63M
Top Buyers
| 1 | +$114M | |
| 2 | +$21.5M | |
| 3 | +$7.71M | |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$6.04M |
| 5 |
RA
Royce & Associates
New York
|
+$3.88M |
Top Sellers
| 1 | -$33.4M | |
| 2 | -$9.55M | |
| 3 | -$8.77M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.61M |
| 5 |
State Street
Boston,
Massachusetts
|
-$7.43M |